Status:
UNKNOWN
Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
Lead Sponsor:
Odense University Hospital
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The main purpose of the study is to investigate the reason for the reduced number of hypoglycaemic attacks in type 1 diabetic patients when, for a period of time, using Insulin Aspart at meals togethe...
Eligibility Criteria
Inclusion
- Type 1 diabetes mellitus treated with insulin four times daily (basal bolus treatment) at least three months before screening.
- AGe: 18-60 years
- BMI: 18-27.5
- No nefro- or neuropathy; i.e. S-creatinin below 120 μmol/l and normal monofilament examination
- Written informed consent
Exclusion
- Pregnant women or patients planning to become pregnant during the investigation period
- Reduced eyesight; i.e. visus \> 0.3 evaluated at the latest eye exam.
- Patient lacking the ability to sens insulin sensitivity
- Serious rival disease, i.e. heart disease, severe liver or lung impairment, severe psychiatric disease.
- Suspicion of abuse or non-compliance
- Participation in another clinical trial
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00145353
Start Date
November 1 2004
End Date
June 1 2006
Last Update
October 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes Research Center
Odense, Funen, Denmark, 5000